{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:40:35Z","timestamp":1793194835167,"version":"4.5.0"},"reference-count":84,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,16]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Fetal\/neonatal alloimmune thrombocytopenia (FNAIT) is a disorder caused by a mismatch in human platelet antigens (HPAs), leading to maternal antibody formation and platelet destruction in the fetus or neonate. The clinically most relevant antigen is HPA-1a on the \u03b23 subunit of integrins \u03b1IIb\u03b23 and \u03b1v\u03b23, which are conformationally regulated cell adhesion receptors on platelets and endothelial cells and are crucial for hemostasis and vascular integrity. The clinical effects of anti-HPA-1a alloimmunization are highly heterogeneous and range from no symptoms to intracranial hemorrhage, potentially causing perinatal death or lifelong complications. However, determinants of disease severity are largely unknown, which hampers implementation of screening programs to identify alloimmunized high-risk women who may benefit from treatment. Using recombinant anti-HPA-1a antibodies and a retrospective cohort of FNAIT samples associated with mild or severe disease, we report that the tested anti-HPA-1a antibodies inhibit binding of integrins \u03b1v\u03b23\/\u03b1IIb\u03b23 to their ligands (vitronectin, fibronectin, and fibrinogen) and impair cell adhesion. This inhibition is dependent on antibody concentration, is mediated by the antibody Fab region, and does not require the Fc tail, and is abolished when integrins are forced into a constitutively extended conformation. Furthermore, the extent of integrin inhibition correlates with disease severity. Together, our data demonstrate that anti-HPA-1a antibodies can block integrin activation, which likely contributes strongly to disease severity in FNAIT. These results may aid development of a prenatal diagnostic test to identify pregnancies at high risk of developing FNAIT and associated severe complications. In addition, these data reveal novel opportunities for allosteric inhibition of \u03b23 integrin activation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025031683","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T17:12:22Z","timestamp":1776186742000},"page":"300-316","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["Maternal anti-HPA-1a antibodies block \u03b1IIb\u03b23\/\u03b1v\u03b23 integrin activation, and blockade correlates with FNAIT disease severity"],"prefix":"10.1182","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7470-847X","authenticated-orcid":false,"given":"Wendy","family":"Stam","sequence":"first","affiliation":[{"name":"1Institute of Biology, Leiden University, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3591-9466","authenticated-orcid":false,"given":"Jeremy D.","family":"Broekhuis","sequence":"additional","affiliation":[{"name":"1Institute of Biology, Leiden University, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7837-7601","authenticated-orcid":false,"given":"Femke W. T.","family":"van der Meer","sequence":"additional","affiliation":[{"name":"1Institute of Biology, Leiden University, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul P.","family":"Pir\u00e9e","sequence":"additional","affiliation":[{"name":"1Institute of Biology, Leiden University, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6749-2594","authenticated-orcid":false,"given":"Janita J.","family":"Oosterhoff","sequence":"additional","affiliation":[{"name":"2Sanquin Research, Amsterdam, The Netherlands"},{"name":"3Department of Biomolecular Mass Spectrometry and Proteomics, Utrecht Institute for Pharmaceutical Sciences and Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8912-6739","authenticated-orcid":false,"given":"Jos\u00e9 Mar\u00eda","family":"de Pereda","sequence":"additional","affiliation":[{"name":"4Centro de Investigaci\u00f3n del C\u00e1ncer and Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas, Universidad de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8065-3540","authenticated-orcid":false,"given":"Ellen","family":"van der Schoot","sequence":"additional","affiliation":[{"name":"2Sanquin Research, Amsterdam, The Netherlands"},{"name":"5Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5621-003X","authenticated-orcid":false,"given":"Gestur","family":"Vidarsson","sequence":"additional","affiliation":[{"name":"2Sanquin Research, Amsterdam, The Netherlands"},{"name":"3Department of Biomolecular Mass Spectrometry and Proteomics, Utrecht Institute for Pharmaceutical Sciences and Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coert","family":"Margadant","sequence":"additional","affiliation":[{"name":"1Institute of Biology, Leiden University, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2026071611220443400_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/vox.12085","article-title":"Human platelet antigens - 2013","volume":"106","author":"Curtis","year":"2014","journal-title":"Vox Sang"},{"issue":"5","key":"2026071611220443400_bib2","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1172\/JCI114082","article-title":"The human platelet alloantigens, PI(A1) and PI(A2), are associated with a leucine33\/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing","volume":"83","author":"Newman","year":"1989","journal-title":"J Clin Invest"},{"issue":"4","key":"2026071611220443400_bib3","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/bjh.20019","article-title":"The potential role of the \u03b1V\u03b23 integrin receptor in placental biology and normal and complicated pregnancies","volume":"206","author":"Rottenstreich","year":"2025","journal-title":"Br J Haematol"},{"issue":"3","key":"2026071611220443400_bib4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/CIRCRESAHA.122.322332","article-title":"Integrin-dependent cell-matrix adhesion in endothelial health and disease","volume":"132","author":"Aman","year":"2023","journal-title":"Circ Res"},{"issue":"suppl 1","key":"2026071611220443400_bib5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1538-7836.2009.03378.x","article-title":"The structure and function of platelet integrins","volume":"7","author":"Bennett","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2026071611220443400_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI5487","article-title":"beta3-integrin-deficient mice are a model for Glanzmann thromboasthenia showing placental defects and reduce survival","volume":"103","author":"Hodivala-Dilke","year":"1999","journal-title":"J Clin Invest"},{"issue":"5158","key":"2026071611220443400_bib7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.7512751","article-title":"Requirement of vascular integrin alphavbeta3 for angiogenesis","volume":"264","author":"Brooks","year":"1994","journal-title":"Science"},{"issue":"5","key":"2026071611220443400_bib8","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1073\/pnas.2628067100","article-title":"Plasma fibronectin promotes thrombus growth and stability in injured arterioles","volume":"100","author":"Ni","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2026071611220443400_bib9","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1182\/blood-2005-10-4168","article-title":"Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi","volume":"107","author":"Cho","year":"2006","journal-title":"Blood"},{"issue":"5","key":"2026071611220443400_bib10","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1538-7836.2005.01217.x","article-title":"Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation","volume":"3","author":"Reheman","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2026071611220443400_bib11","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1182\/blood-2003-12-4293","article-title":"Fibrin-incorporated vitronectin is involved in platelet adhesion and thrombus formation through homotypic interactions with platelet-associated vitronectin","volume":"104","author":"Wu","year":"2004","journal-title":"Blood"},{"issue":"10","key":"2026071611220443400_bib12","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1111\/j.1538-7836.2006.02116.x","article-title":"Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo","volume":"4","author":"Yang","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2026071611220443400_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI9896","article-title":"Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen","volume":"106","author":"Ni","year":"2000","journal-title":"J Clin Invest"},{"issue":"2","key":"2026071611220443400_bib14","doi-asserted-by":"crossref","first-page":"a005132","DOI":"10.1101\/cshperspect.a005132","article-title":"Extracellular matrix proteins in hemostasis and thrombosis","volume":"4","author":"Bergmeier","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"2026071611220443400_bib15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/MOH.0000000000000237","article-title":"Extracellular matrix proteins in the regulation of thrombus formation","volume":"23","author":"Wang","year":"2016","journal-title":"Curr Opin Hematol"},{"issue":"11","key":"2026071611220443400_bib16","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1172\/JCI57850","article-title":"The maternal immune response to fetal platelet GPIb\u03b1 causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies","volume":"121","author":"Li","year":"2011","journal-title":"J Clin Invest"},{"issue":"18","key":"2026071611220443400_bib17","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1182\/blood-2010-08-299404","article-title":"FNAIT: the fetus pleads guilty","volume":"116","author":"Kaplan","year":"2010","journal-title":"Blood"},{"issue":"18","key":"2026071611220443400_bib18","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1182\/blood-2010-05-284919","article-title":"Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy","volume":"116","author":"Chen","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2026071611220443400_bib19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ajog.2021.04.211","article-title":"New developments in fetal and neonatal alloimmune thrombocytopenia","volume":"225","author":"Bussel","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2026071611220443400_bib20","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI77820","article-title":"Maternal anti-platelet \u03b23 integrins impair angiogenesis and cause intracranial hemorrhage","volume":"125","author":"Yougbar\u00e9","year":"2015","journal-title":"J Clin Invest"},{"issue":"1","key":"2026071611220443400_bib21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41467-017-00269-1","article-title":"Activated NK cells cause placental dysfunction and miscarriages in fetal alloimmune thrombocytopenia","volume":"8","author":"Yougbar\u00e9","year":"2017","journal-title":"Nat Commun"},{"issue":"June","key":"2026071611220443400_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.placenta.2021.07.291","article-title":"Platelet alloimmunization is associated with low grade chronic histiocytic intervillositis - a new link to a rare placental lesion?","volume":"112","author":"Nedberg","year":"2021","journal-title":"Placenta"},{"issue":"13","key":"2026071611220443400_bib23","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.3390\/ijms22136763","article-title":"Placental complement activation in fetal and neonatal alloimmune thrombocytopenia: an observational study","volume":"22","author":"de Vos","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026071611220443400_bib24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.placenta.2016.10.009","article-title":"Placental histological lesions in fetal and neonatal alloimmune thrombocytopenia: a retrospective cohort study of 21 cases","volume":"48","author":"Dubruc","year":"2016","journal-title":"Placenta"},{"issue":"8634","key":"2026071611220443400_bib25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0140-6736(89)91733-9","article-title":"348 cases of suspected neonatal alloimmune thrombocytopenia","volume":"333","author":"Mueller-Eckhardt","year":"1989","journal-title":"The Lancet"},{"issue":"4","key":"2026071611220443400_bib26","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1542\/peds.2013-3320","article-title":"Incidence and consequences of neonatal alloimmune thrombocytopenia: a systematic review","volume":"133","author":"Kamphuis","year":"2014","journal-title":"Pediatrics"},{"key":"2026071611220443400_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2147\/IJWH.S90753","article-title":"Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities","volume":"9","author":"Tiller","year":"2017","journal-title":"Int J Womens Health"},{"issue":"1","key":"2026071611220443400_bib28","doi-asserted-by":"crossref","first-page":"102704","DOI":"10.1016\/j.transci.2019.102704","article-title":"Epidemiology and management of fetal and neonatal alloimmune thrombocytopenia","volume":"59","author":"de Vos","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"11","key":"2026071611220443400_bib29","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood-2016-10-739656","article-title":"Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review","volume":"129","author":"Winkelhorst","year":"2017","journal-title":"Blood"},{"issue":"5","key":"2026071611220443400_bib30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1471-0528.2000.tb13315.x","article-title":"Neonatal alloimmune thrombocytopenia due to anti-HPA 1a antibodies; the level of maternal antibodies predicts the severity of thrombocytopenia in the newborn","volume":"107","author":"J\u00e6gtvik","year":"2000","journal-title":"BJOG"},{"issue":"1","key":"2026071611220443400_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/trf.13274","article-title":"Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage","volume":"56","author":"Delbos","year":"2016","journal-title":"Transfusion"},{"issue":"6","key":"2026071611220443400_bib32","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3324\/haematol.12515","article-title":"A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn","volume":"93","author":"Killie","year":"2008","journal-title":"Haematologica"},{"issue":"1","key":"2026071611220443400_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/vox.12725","article-title":"Maternal HPA-1a antibody level and its role in predicting the severity of fetal\/neonatal alloimmune thrombocytopenia: a systematic review","volume":"114","author":"Kj\u00e6r","year":"2019","journal-title":"Vox Sang"},{"issue":"4","key":"2026071611220443400_bib34","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/blood-2013-09-527978","article-title":"A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy","volume":"123","author":"Kapur","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2026071611220443400_bib35","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/bjh.14053","article-title":"Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia","volume":"174","author":"Sonneveld","year":"2016","journal-title":"Br J Haematol"},{"issue":"4","key":"2026071611220443400_bib36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-2141.1994.tb06742.x","article-title":"Analysis of immunoglobulin class, IgG subclass and titre of HPA-1a antibodies in alloimmunized mothers giving birth to babies with or without neonatal alloimmune thrombocytopenia","volume":"87","author":"Proulx","year":"1994","journal-title":"Br J Haematol"},{"issue":"12","key":"2026071611220443400_bib37","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/j.1537-2995.2005.00645.x","article-title":"Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a","volume":"45","author":"Turner","year":"2005","journal-title":"Transfusion (Paris)"},{"issue":"7","key":"2026071611220443400_bib38","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/j.1537-2995.2007.01273.x","article-title":"HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia","volume":"47","author":"Ghevaert","year":"2007","journal-title":"Transfusion (Paris)"},{"key":"2026071611220443400_bib39","doi-asserted-by":"crossref","first-page":"1283704","DOI":"10.3389\/fimmu.2023.1283704","article-title":"In vitro analysis of anti-HPA-1a dependent platelet phagocytosis and its inhibition using a new whole blood phagocytosis assay (WHOPPA)","volume":"14","author":"Ames","year":"2023","journal-title":"Front Immunol"},{"issue":"2","key":"2026071611220443400_bib40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1034\/j.1600-0609.2003.00025.x","article-title":"Anti-HPA-1a-mediated platelet phagocytosis by monocytes in vitro and its inhibition by Fc gamma receptor (Fc\u03b3R) reactive reagents","volume":"70","author":"Wiener","year":"2003","journal-title":"Eur J Haematol"},{"issue":"8","key":"2026071611220443400_bib41","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/ATVBAHA.116.307281","article-title":"Antiendothelial \u03b1v\u03b23 antibodies are a major cause of intracranial bleeding in fetal\/neonatal alloimmune thrombocytopenia","volume":"36","author":"Santoso","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"2026071611220443400_bib42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000515703","article-title":"Maternal anti-HPA-1a antibodies increase endothelial cell apoptosis and permeability","volume":"58","author":"Dardik","year":"2021","journal-title":"J Vasc Res"},{"issue":"10","key":"2026071611220443400_bib43","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood-2014-11-611020","article-title":"Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodies","volume":"126","author":"Liu","year":"2015","journal-title":"Blood"},{"key":"2026071611220443400_bib44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.thromres.2017.12.017","article-title":"Adding to the complexity of fetal and neonatal alloimmune thrombocytopenia: reduced fibrinogen binding in the presence of anti-HPA-1a antibody and hypo-responsive neonatal platelets","volume":"162","author":"Refsum","year":"2018","journal-title":"Thromb Res"},{"issue":"6","key":"2026071611220443400_bib45","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1160\/TH05-03-0159","article-title":"Functional heterogeneity of alloantibodies against the human platelet antigen (HPA)-1a","volume":"94","author":"Kroll","year":"2005","journal-title":"Thromb Haemost"},{"issue":"4","key":"2026071611220443400_bib46","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1160\/TH03-07-0484","article-title":"The effect of recombinant lgG antibodies against the leucine-33 form of the platelet \u03b23 integrin (HPA-la) on platelet function","volume":"91","author":"Joutsi-Korhonen","year":"2004","journal-title":"Thromb Haemost"},{"issue":"1","key":"2026071611220443400_bib47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12958-017-0245-6","article-title":"Anti-human platelet antigen (HPA)-1a antibodies may affect trophoblast functions crucial for placental development: a laboratory study using an in vitro model","volume":"15","author":"Eksteen","year":"2017","journal-title":"Reprod Biol Endocrinol"},{"issue":"11","key":"2026071611220443400_bib48","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.str.2017.09.007","article-title":"The therapeutic antibody LM609 selectively inhibits ligand binding to human \u03b1V\u03b23 integrin via steric hindrance","volume":"25","author":"Borst","year":"2017","journal-title":"Structure"},{"issue":"3","key":"2026071611220443400_bib49","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/ATVBAHA.119.313671","article-title":"Cryo-electron microscopy structure of the \u03b1IIb\u03b23-abciximab complex","volume":"40","author":"Ne\u0161i\u0107","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2026071611220443400_bib50","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1182\/blood.V64.1.59.59","article-title":"A Murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins Ilb and\/or Illa","volume":"64","author":"Coller","year":"1984","journal-title":"Blood"},{"issue":"13","key":"2026071611220443400_bib51","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood-2016-07-729400","article-title":"The integrin PSI domain has an endogenous thiol isomerase function and is a novel target for antiplatelet therapy","volume":"129","author":"Zhu","year":"2017","journal-title":"Blood"},{"key":"2026071611220443400_bib52","doi-asserted-by":"crossref","first-page":"101038","DOI":"10.1016\/j.blre.2022.101038","article-title":"Fetal and neonatal alloimmune thrombocytopenia: current pathophysiological insights and perspectives for future diagnostics and treatment","volume":"59","author":"Stam","year":"2023","journal-title":"Blood Rev"},{"issue":"21","key":"2026071611220443400_bib53","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1182\/bloodadvances.2018023341","article-title":"High-resolution mapping of the polyclonal immune response to the human platelet alloantigen HPA-1a (PlA1)","volume":"2","author":"Zhi","year":"2018","journal-title":"Blood Adv"},{"issue":"39","key":"2026071611220443400_bib54","doi-asserted-by":"crossref","first-page":"9105","DOI":"10.1073\/pnas.1806205115","article-title":"Autonomous conformational regulation of \u03b23 integrin and the conformation-dependent property of HPA-1a alloantibodies","volume":"115","author":"Thinn","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2026071611220443400_bib55","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1111\/trf.15960","article-title":"Naturally occurring point mutation Cys460Trp located in the I-EGF1 domain of integrin \u03b23 alters the binding of some anti-HPA-1a antibodies","volume":"60","author":"Holzwarth","year":"2020","journal-title":"Transfusion (Paris)"},{"issue":"2","key":"2026071611220443400_bib56","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1538-7836.2008.02858.x","article-title":"Immunologic and structural analysis of eight novel domain-deletion \u03b23 integrin peptides designed for detection of HPA-1 antibodies","volume":"6","author":"Stafford","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2026071611220443400_bib57","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1182\/blood.V99.5.1833","article-title":"HPA-1a phenotype-genotype discrepancy reveals a naturally occurring Arg93Gln substitution in the platelet beta3 integrin that disrupts the HPA-1a epitope","volume":"99","author":"Watkins","year":"2002","journal-title":"Blood"},{"issue":"11","key":"2026071611220443400_bib58","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1182\/blood.V85.11.3028.bloodjournal85113028","article-title":"Involvement of the cysteine-rich domain of glycoprotein IIIa in the expression of the human platelet alloantigen, Pl(A1): evidence for heterogeneity in the humoral response","volume":"85","author":"Valentin","year":"1995","journal-title":"Blood"},{"issue":"5","key":"2026071611220443400_bib59","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0092-8674(02)00935-2","article-title":"Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling","volume":"110","author":"Takagi","year":"2002","journal-title":"Cell"},{"issue":"4","key":"2026071611220443400_bib60","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nrm2871","article-title":"The final steps of integrin activation: the end game","volume":"11","author":"Shattil","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"2026071611220443400_bib61","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ceb.2006.08.005","article-title":"Integrin structures and conformational signaling","volume":"18","author":"Luo","year":"2006","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"2026071611220443400_bib62","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood.2019003336","article-title":"Activation and suppression of hematopoietic integrins in hemostasis and immunity","volume":"135","author":"Nolte","year":"2020","journal-title":"Blood"},{"issue":"18","key":"2026071611220443400_bib63","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1182\/blood.2025029618","article-title":"HPA-1a antibodies in FNAIT do not distinguish \u03b1v\u03b23 from \u03b1IIb\u03b23 and bind inactive integrins more strongly than active integrins","volume":"146","author":"Oosterhoff","year":"2025","journal-title":"Blood"},{"issue":"10","key":"2026071611220443400_bib64","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1182\/blood-2012-06-437723","article-title":"A novel flow cytometry-based platelet aggregation assay","volume":"121","author":"De Cuyper","year":"2013","journal-title":"Blood"},{"issue":"10","key":"2026071611220443400_bib65","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1182\/blood-2013-08-519686","article-title":"Functional platelet defects in children with severe chronic ITP as tested with 2 novel assays applicable for low platelet counts","volume":"123","author":"Van Bladel","year":"2014","journal-title":"Blood"},{"issue":"12","key":"2026071611220443400_bib66","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1182\/blood.V86.12.4430.bloodjournal86124430","article-title":"A human monoclonal antibody specific for the leucine-33 (PIA\u2019, HPA-la) form of platelet glycoprotein IIIa from a V gene phage display library","volume":"86","author":"Griffin","year":"1995","journal-title":"Blood"},{"issue":"12","key":"2026071611220443400_bib67","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.4049\/jimmunol.1401599","article-title":"Characterization of a human platelet antigen-1a\u2013specific monoclonal antibody derived from a B cell from a woman alloimmunized in pregnancy","volume":"194","author":"Eksteen","year":"2015","journal-title":"J Immunol"},{"issue":"5","key":"2026071611220443400_bib68","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/trf.17758","article-title":"Generation of human antibodies targeting human platelet antigen (HPA)-1a","volume":"64","author":"Oosterhoff","year":"2024","journal-title":"Transfusion (Paris)"},{"issue":"3","key":"2026071611220443400_bib69","doi-asserted-by":"crossref","first-page":"102473","DOI":"10.1016\/j.xpro.2023.102473","article-title":"Imaging and quantitative analysis of integrin-dependent cell-matrix adhesions","volume":"4","author":"van Stalborch","year":"2023","journal-title":"STAR Protoc"},{"issue":"6","key":"2026071611220443400_bib70","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.molcel.2008.11.018","article-title":"Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces","volume":"32","author":"Zhu","year":"2008","journal-title":"Mol Cell"},{"issue":"4","key":"2026071611220443400_bib71","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1083\/jcb.200801146","article-title":"Structural basis for distinctive recognition of fibrinogen \u03b3C peptide by the platelet integrin \u03b1IIb\u03b23","volume":"182","author":"Springer","year":"2008","journal-title":"J Cell Biol"},{"key":"2026071611220443400_bib72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-0716-0962-0_1","article-title":"Measurement of integrin activation and conformational changes on the cell surface by soluble ligand and antibody binding assays","volume":"2217","author":"Wang","year":"2021","journal-title":"Methods Mol Biol"},{"key":"2026071611220443400_bib73","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/978-1-61779-166-6_20","article-title":"Talin and signaling through integrins","volume":"757","author":"Bouaouina","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"2","key":"2026071611220443400_bib74","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1083\/jcb.113.2.451","article-title":"Adhesive properties of the beta3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells","volume":"113","author":"Kieffer","year":"1991","journal-title":"J Cell Biol"},{"issue":"1","key":"2026071611220443400_bib75","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1038\/s41467-023-39763-0","article-title":"Cryo-EM structures of full-length integrin \u03b1IIb\u03b23 in native lipids","volume":"14","author":"Adair","year":"2023","journal-title":"Nat Commun"},{"issue":"12","key":"2026071611220443400_bib76","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.1074\/jbc.271.12.6571","article-title":"Breaking the integrin hinge: a defined structural constraint regulates integrin signaling","volume":"271","author":"Hughes","year":"1996","journal-title":"J Biol Chem"},{"issue":"5","key":"2026071611220443400_bib77","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1073\/pnas.0438060100","article-title":"Stabilizing the open conformation of the integrin headpiece with a glycan wedge increases affinity for ligand","volume":"100","author":"Luo","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"pt 22","key":"2026071611220443400_bib78","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1242\/jcs.056770","article-title":"Anti-integrin monoclonal antibodies","volume":"122","author":"Byron","year":"2009","journal-title":"J Cell Sci"},{"issue":"12","key":"2026071611220443400_bib79","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1016\/j.cell.2024.04.049","article-title":"Ligand binding initiates single-molecule integrin conformational activation","volume":"187","author":"Li","year":"2024","journal-title":"Cell"},{"issue":"5","key":"2026071611220443400_bib80","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41590-024-01802-3","article-title":"Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicity","volume":"25","author":"Hamid","year":"2024","journal-title":"Nat Immunol"},{"issue":"7","key":"2026071611220443400_bib81","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/j.1537-2995.2011.03480.x","article-title":"Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model","volume":"52","author":"Tiller","year":"2012","journal-title":"Transfusion (Paris)"},{"issue":"20","key":"2026071611220443400_bib82","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1182\/blood.2022015666","article-title":"Prophylactic administration of HPA-1a-specific antibodies prevents fetal\/neonatal alloimmune thrombocytopenia in mice","volume":"140","author":"Zhi","year":"2022","journal-title":"Blood"},{"issue":"1","key":"2026071611220443400_bib83","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41573-021-00284-4","article-title":"Emerging therapeutic opportunities for integrin inhibitors","volume":"21","author":"Slack","year":"2022","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2026071611220443400_bib84","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13045-019-0709-6","article-title":"Platelet integrin \u03b1IIb\u03b23: signal transduction, regulation, and its therapeutic targeting","volume":"12","author":"Huang","year":"2019","journal-title":"J Hematol Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/3\/300\/2533914\/blood_bld-2025-031683-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/3\/300\/2533914\/blood_bld-2025-031683-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:22:18Z","timestamp":1784215338000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/148\/3\/300\/567754\/Maternal-anti-HPA-1a-antibodies-block-IIb-3-v-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7,16]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025031683","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7,16]]},"published":{"date-parts":[[2026,7,16]]}}}